These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 26304753)
1. Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase. Hou HH; Liao YJ; Hsiao SH; Shyue SK; Lee TS Sci Rep; 2015 Aug; 5():13524. PubMed ID: 26304753 [TBL] [Abstract][Full Text] [Related]
2. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase. Hou HH; Hammock BD; Su KH; Morisseau C; Kou YR; Imaoka S; Oguro A; Shyue SK; Zhao JF; Lee TS Cardiovasc Res; 2012 Jan; 93(1):120-9. PubMed ID: 22072631 [TBL] [Abstract][Full Text] [Related]
3. The essential role of transient receptor potential vanilloid 1 in simvastatin-induced activation of endothelial nitric oxide synthase and angiogenesis. Su KH; Lin SJ; Wei J; Lee KI; Zhao JF; Shyue SK; Lee TS Acta Physiol (Oxf); 2014 Nov; 212(3):191-204. PubMed ID: 25183024 [TBL] [Abstract][Full Text] [Related]
4. Phosphatase activity of soluble epoxide hydrolase. Kramer J; Proschak E Prostaglandins Other Lipid Mediat; 2017 Nov; 133():88-92. PubMed ID: 28729091 [TBL] [Abstract][Full Text] [Related]
5. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth. Oguro A; Sakamoto K; Suzuki S; Imaoka S Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412 [TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury. Ding Y; Li Y; Zhang X; He J; Lu D; Fang X; Wang Y; Wang J; Zhang Y; Qiao X; Gan LM; Chen C; Zhu Y J Mol Cell Cardiol; 2017 Sep; 110():70-79. PubMed ID: 28736260 [TBL] [Abstract][Full Text] [Related]
7. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases. Ning WH; Zhao K Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990 [TBL] [Abstract][Full Text] [Related]
8. A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway. Xu L; Wang S; Li B; Sun A; Zou Y; Ge J J Cell Mol Med; 2015 Jan; 19(1):92-102. PubMed ID: 25388834 [TBL] [Abstract][Full Text] [Related]
9. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940 [TBL] [Abstract][Full Text] [Related]
10. Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries. Rossoni LV; Wareing M; Wenceslau CF; Al-Abri M; Cobb C; Austin C Clin Sci (Lond); 2011 Nov; 121(10):449-58. PubMed ID: 21671887 [TBL] [Abstract][Full Text] [Related]
11. Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway. Hien TT; Oh WK; Nguyen PH; Oh SJ; Lee MY; Kang KW Mol Pharmacol; 2011 Dec; 80(6):1166-78. PubMed ID: 21940786 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704 [TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis. Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809 [TBL] [Abstract][Full Text] [Related]
15. Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase. EnayetAllah AE; Luria A; Luo B; Tsai HJ; Sura P; Hammock BD; Grant DF J Biol Chem; 2008 Dec; 283(52):36592-8. PubMed ID: 18974052 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of Xenopus soluble epoxide hydrolase. Purba ER; Oguro A; Imaoka S Biochim Biophys Acta; 2014 Jul; 1841(7):954-62. PubMed ID: 24681163 [TBL] [Abstract][Full Text] [Related]
17. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. Fleming I; Fisslthaler B; Dixit M; Busse R J Cell Sci; 2005 Sep; 118(Pt 18):4103-11. PubMed ID: 16118242 [TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway. Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738 [TBL] [Abstract][Full Text] [Related]